Standout Papers

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer 2004 2026 2011 2018 4.3k
  1. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer (2004)
    Ian F. Tannock, Ronald de Wit et al. New England Journal of Medicine
  2. Glioma (2015)
    Michael Weller, Wolfgang Wick et al. Nature Reviews Disease Primers
  3. Reference Ranges for Spirometry Across All Ages (2007)
    Sanja Stanojevic, Angie Wade et al. American Journal of Respiratory and Critical Care Medicine

Immediate Impact

5 by Nobel laureates 16 from Science/Nature 81 standout
Sub-graph 1 of 19

Citing Papers

Fluorescent Probes for Disease Diagnosis
2024 Standout
Metabolic reprogramming in cancer: Mechanisms and therapeutics
2023 Standout

Works of Mark Rosenthal being referenced

Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial
2022
Glioma
2015 Standout

Author Peers

Author Last Decade Papers Cites
Mark Rosenthal 5812 1575 2721 2256 203 10.0k
Faith G. Davis 2820 2905 2447 2105 144 10.1k
Patrick J. Flynn 2563 1337 6762 2177 144 10.9k
Samuel Hellmän 3005 724 3766 1374 234 10.6k
Sjoerd Rodenhuis 4238 960 5971 3602 253 12.7k
Kimberly Blackwell 2367 777 5876 2095 139 8.9k
Sijin Wen 2705 2177 2965 2244 296 10.1k
Judith R. OʼFallon 3284 5482 2110 2014 125 11.0k
Francesco Cognetti 2271 517 4930 2319 221 8.3k
Vittorina Zagonel 2331 2223 5225 2076 459 11.2k
Andrew D. Seidman 2423 711 7951 2133 206 10.8k

All Works

Loading papers...

Rankless by CCL
2026